European Commission

News

EU first to clear AbbVie's Rinvoq for alopecia areata

AbbVie's fast-growing JAK inhibitor Rinvoq has been cleared for alopecia areata in the EU, its first market for the hair loss disorder.

News

EU clears AZ's SERD camizestrant, as FDA review drags on

AstraZeneca's new breast cancer therapy Etcamah claims landmark frontline approval in the EU, but its prospects in the US are less certain.

News

Moderna's mResvia gets shot in the arm from EU contract

A new EU procurement contract could give Moderna's RSV shot mResvia, which has struggled to gain traction in the market, a welcome boost.

News

EU seeks advice on Sanofi's response to mismarketing claim

The EU is asking for feedback on measures proposed by Sanofi to address concerns about an allegedly misleading marketing campaign for a flu vaccine.

News

Sanofi faces EU investigation over flu shot marketing

The European Commission is investigating a marketing campaign run by Sanofi for a flu vaccine, to see if it disparaged its only rival in the market.

News

EU invests €30m to fight antimicrobial resistance

The EU has pledged €30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.

EU first to clear AbbVie's Rinvoq for alopecia areata

EU clears AZ's SERD camizestrant, as FDA review drags on

Moderna's mResvia gets shot in the arm from EU contract

EU seeks advice on Sanofi's response to mismarketing claim

Sanofi faces EU investigation over flu shot marketing

EU invests €30m to fight antimicrobial resistance

TransThera's resistant biliary cancer drug cleared in China

Discover a new era of healthcare panel engagement: Grounded ...

European Commission

Editor's Picks